"Pulmonary function tests (PFTs) are often consistent with an overall decrease in airflow and diffusing capacity. Airflow tends to improve post-recovery whereas diffusing capacity does not 20."
"Vaping-associated lung disease, or EVALI (e-cigarette or vaping product use-associated lung injury), consists of patterns of inhalational pulmonary injury induced by electronic cigarettes (also known as e-cigarettes, e-vaporisers, e-hookahs, vapes, vape pens). These products heat up a liquid containing nicotine (in which case the device is formally also called an electronic nicotine delivery system (ENDS)) or cannabinoids (such as tetrahydrocannabinol or cannabidiol, in which case the process is also colloquially called "dabbing"). The user then inhales the aerosol generated."
"Electronic nicotine delivery systems (ENDS) have been available in the USA since 2007, however the first case report was not published until 2013 20."
"absence of pulmonary infection (demonstrated by locally appropriate and clinically indicated testing such as respiratory viral panel, influenza polymerase chain reaction or rapid test, urine antigens of Streptococcus pneumoniae and Legionella spp., sputum culture, bronchoalveolar lavage, blood culture, human immunodeficiency virus-related opportunistic infections)"
"no evidence of other plausible diagnoses (e.g. cardiac, rheumatologic, or neoplastic process)"
"Vaping-associated lung disease, or EVALI (e-cigarette or vaping product use-associated lung injury), consists of patterns of inhalational pulmonary injury induced by electronic cigarettes (also known as e-cigarettes, e-vaporisers, e-hookahs, vapes, vape pens). These products heat up a liquid containing nicotine (in which case the device is formally also called an electronic nicotine delivery system (ENDS)) or cannabinoids (such as tetrahydrocannabinol or cannabidiol, in which case the process is also colloquially called "dabbing"). The user then inhales the aerosol generated."
"absence of pulmonary infection (demonstrated by locally appropriate and clinically indicated testing such as respiratory viral panel, influenza polymerase chain reaction or rapid test, urine antigens of Streptococcus pneumoniae and Legionella spp., sputum culture, bronchoalveolar lavage, blood culture, human immunodeficiency virus-related opportunistic infections)"
"Vaping-associated lung disease, or EVALI (e-cigarette or vaping product use-associated lung injury), consists of patterns of inhalational pulmonary injury induced by electronic cigarettes (also known as e-cigarettes, e-vaporisers, e-hookahs, vapes, vape pens). These products heat up a liquid containing nicotine (in which case the device is formally also called an electronic nicotine delivery system (ENDS)) or cannabinoids (such as tetrahydrocannabinol or cannabidiol, in which case the process is also colloquially called "dabbing"). The user then inhales the aerosol generated."
"no evidence of other plausible diagnoses (e.g. cardiac, rheumatologic, or neoplastic process)"
"basilar predominant ground glass opacities, nodular or tree-in-bud opacities, crazy paving"